Effects of capecitabine: A Synthesis of Findings from 14 Studies
- Home
- Effects of capecitabine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of capecitabine: A Synthesis of Findings from 14 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Capecitabine has shown promising results in treating various types of cancer, including breast cancer, colorectal cancer, and gastric cancer. 3 14 6 4 10 When used in combination with other chemotherapy agents, such as oxaliplatin, it can be even more effective, particularly in the treatment of metastatic colorectal cancer. 10 Additionally, capecitabine has demonstrated a potential benefit in the treatment of triple-negative breast cancer, especially when combined with a Wee1 inhibitor like adavosertib. 9 However, it's important to note that capecitabine can cause adverse effects, such as hand-foot syndrome, diarrhea, and potentially severe complications in individuals with Dihydropyrimidine Dehydrogenase (DPD) deficiency. 5 8 12 Elderly patients seem to be more prone to experiencing these side effects. 11 Researchers are exploring ways to enhance the effectiveness of capecitabine, such as by using genetic information to predict how patients will respond to treatment. 13
Benefits and Risks
Benefit Summary
Capecitabine has demonstrated its potential to improve disease-free survival, distant disease-free survival, and overall survival in patients with early breast cancer. 3 It also shows promise in improving pathological complete response rates in neoadjuvant chemotherapy settings. 3 Furthermore, capecitabine's combination therapy with other chemotherapy agents has proven effective, specifically in treating metastatic colorectal cancer and potentially enhancing the treatment outcome for triple-negative breast cancer. 9 10
Risk Summary
Common side effects of capecitabine include hand-foot syndrome and diarrhea. 5 8 Moreover, capecitabine can cause serious adverse effects in individuals with Dihydropyrimidine Dehydrogenase (DPD) deficiency. 12 Elderly patients are more susceptible to these side effects. 11
Comparison Across Studies
Similarities in Studies
Several studies have consistently shown the effectiveness of capecitabine in treating various types of cancer, including breast cancer, colorectal cancer, and gastric cancer. 3 14 6 4 10 Capecitabine's efficacy is often enhanced when combined with other chemotherapy drugs. 9 10
Differences in Studies
The effectiveness and side effects of capecitabine can vary depending on the type of cancer being treated, the specific treatment regimen, and individual patient factors. 3 14 6 4 10 The frequency and severity of side effects also differ between individuals. 5 8 12 11
Consistency and Inconsistencies in Findings
The research on capecitabine demonstrates its potential as a valuable treatment for a range of cancers. 3 14 6 4 10 However, a crucial consideration is the variability in side effect occurrence and severity among individuals. 5 8 12 11 Furthermore, the risk of severe adverse effects in individuals with DPD deficiency highlights the importance of careful patient evaluation before administering capecitabine. 12
Considerations for Real-World Application
Capecitabine is a promising drug in cancer treatment, but it comes with potential side effects. 5 8 12 11 It's crucial to follow your doctor's instructions regarding dosage and administration to maximize its benefits while minimizing risks. 3 If you are considering capecitabine treatment, a DPD deficiency test is recommended to assess potential risks. 12
Limitations of Current Research
Some studies on capecitabine have limited sample sizes or may focus on specific patient populations. 3 14 6 4 10 Additional research is needed to comprehensively understand the effectiveness and side effects of capecitabine. 5 8 12 11
Future Research Directions
Large-scale clinical trials are necessary to further investigate the efficacy and side effects of capecitabine. 3 14 6 4 10 Further research is crucial to identify those patients who are most likely to benefit from capecitabine treatment. 5 8 12 11
Conclusion
Capecitabine shows promise as a valuable treatment option for various cancers. 3 14 6 4 10 However, it's essential to be aware of its potential side effects. 5 8 12 11 Therefore, it is crucial to follow your doctor's instructions regarding dosage and administration and consider getting a DPD deficiency test before starting capecitabine treatment. 3 12 While capecitabine plays a significant role in cancer treatment, it's vital to carefully consider patient-specific factors, potential side effects, and the importance of close monitoring during treatment.
Benefit Keywords
Risk Keywords
Article Type
Author: WangYongqing, YangHaiwei, WeiJi-Fu, MengLing
Language : English
Author: XuJinrong, LinZeshuai, ChenJiani, ZhangJian, LiWanqing, ZhangRui, XingJin, YeZhihuan, LiuXiaoping, GaoQianmin, ChenXintao, ZhaiJingwen, YaoHoushan, LiMingming, WeiHua
Language : English
Author: van MackelenberghMarion T, SeitherFenja, MöbusVolker, O'ShaughnessyJoyce, MartinMiguel, JoensuuHeikki, UntchMichael, NitzUlrike, StegerGuenther G, MirallesJuan J, BarriosCarlos H, ToiMasakazu, BearHarry D, MussHyman, ReimerToralf, NekljudovaValentina, LoiblSibylle
Language : English
Author: NagahisaSeiichi, WatanabeMegumi, MinagiHitoshi, OgawaToshihiro, ArakiHiroyuki, KimuraYuji, TaniguchiFumitaka, ArataTakashi, KatsudaKo, TanakayaKoji, AokiHideki
Language : Japanese
Author: DI StasoFederico, GattazzoIrene, SalimbeniBeatrice Taurelli, LambiaseAlessandro, ScuderiGianluca, DI StasoSilvio, CiancagliniMarco
Language : English
Author: FuJie, WangChun-Yan, WangChun-Gang, LiHong-Ling, YangXiao-Jing, SunYi, ShaoYu-Hui, ZhangLi-Hua, YangXin-Miao, ZhangXiu-Long
Language : English
Author: CharalambousAndreas, TsitsiTheologia, AstrasGeorge, PaikousisLefkios, FilippouElena
Language : English
Author: Nakano-TatenoTae, SatouMotoyasu, InoshitaNaoko, van LandeghemFrank K H, EasawJay, MehtaVivek, TatenoToru, ChikConstance L
Language : English
Author: PittsTodd M, SimmonsDennis M, BagbyStacey M, HartmanSarah J, YacobBetelehem W, GittlemanBrian, TentlerJohn J, CittellyDiana, OrmondD Ryan, MessersmithWells A, EckhardtS Gail, DiamondJennifer R
Language : English
Author: WeiLi, ChenJie, WenJingyun, WuDonghao, MaXiaokun, ChenZhanhong, HuangJianglong
Language : English
Author: van BeekMichiel W H, RoukensMonique, JacobsWilco C H, Timmer-BonteJohanna N H, KramersCees
Language : English
Author: InoueHiroto, SatoYuto, ShintaniShuuhei, TanabeHiroki, BambaHiromichi, KomaiYasunobu, NakamuraTomoaki, ImaiTakayuki, AndouAkira
Language : Japanese
Author: ZhouXinna, QiaoGuoliang, WangXiaoli, SongQingkun, MorseMichael A, HobeikaAmy, GwinWilliam R, RenJun, LyerlyH Kim
Language : English
Author: MohammadianMahshid, ZeynaliShima, AzarbaijaniAnahita Fathi, Khadem AnsariMohammad Hassan, KheradmandFatemeh
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.